Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1-driven gluconeogenesis.
Liu N, Yang X, Guo J, Zhang L, Huang S, Chen J, Huang J, Chen Y, Cui T, Zheng Y, Li T, Tang K, Zhong Y, Duan S, Yu L, Tang Y, Zheng D, Pan H, Gao Y.
Liu N, et al. Among authors: tang y, tang k.
EMBO Rep. 2023 Jun 5;24(6):e56390. doi: 10.15252/embr.202256390. Epub 2023 May 8.
EMBO Rep. 2023.
PMID: 37154299
Free PMC article.